# US 2006/0051368 A1 · Herpes simplex virus mutations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0051368 A1
- Document ID: US20060051368A1
- Status: Published application
- Kind: A1
- Application number: 11/187,652
- Filed: 2005-07-22
- Published: 2006-03-09
- Earliest claimed: 2004-07-23
- Assignees: Northwestern University
- Inventors: Patricia Spear; Sharmila Manoj; Cheryl Jogger; Dawn Myscofski; Miri Yoon
- Web page: https://patentgrep.com/patent/US20060051368A1

## CPC

- C07K 14/005: from viruses
- A61K 2039/525: {Virus}
- C12N 2710/16622: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention relates to compositions and methods related to mutant herpes simplex virus nucleic acid and proteins that find use in analyzing, diagnosing, and regulating viral infection.

## Claims

### Claim 1

A composition, comprising a herpes simplex virus wherein said herpes simplex virus expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain.

### Claim 2 (depends on 1)

The herpes simplex virus of claim 1, wherein said herpes simplex virus expresses two or more amino acid substitutions selected from the group consisting of substitutions at amino acid positions 215, 222, and 223 of the glycoprotein D (gD) ectodomain.

### Claim 3

A method for eliciting an immune response in an organism, comprising:
a) providing an organism;
b) providing a herpes simplex virus wherein said herpes simplex virus expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain; and
c) contacting said organism with said herpes simplex virus such that said organism manifests an immune response.

### Claim 4 (depends on 3)

The herpes simplex virus of claim 3, wherein said herpes simplex virus expresses two or more amino acid substitutions selected from the group consisting of substitutions at amino acid positions 215, 222, and 223 of the glycoprotein D (gD) ectodomain.

### Claim 5

A method for expressing a heterologous nucleic acid sequence in a cell, comprising:
d) providing a cell;
e) providing a herpes simplex virus vector wherein said herpes simplex virus vector expresses at least one amino acid substitution selected from the group consisting of substitutions at amino acid positions 27, 30, 38, 215, 222, and 223 of the glycoprotein D (gD) ectodomain;
f) providing a heterologous nucleic acid sequence; and
g) transfecting said cell with said herpes simplex virus vector containing said nucleic acid sequence such that said nucleic acid sequence is expressed in said cell.

### Claim 6 (depends on 5)

The method of claim 5, wherein said cell is selected from the group consisting of an epithelial cell and a neuronal cell.

### Claim 7 (depends on 6)

The method of claim 6, wherein said herpes simplex virus expresses at least one more amino acid substitutions selected from the group consisting of substitutions at amino acid positions 27 and 30 of the glycoprotein D (gD) ectodomain.

### Claim 8 (depends on 8)

The method of claim 8, wherein said cell is selected from the group consisting of a lymphocyte and a leukocyte.

### Claim 9 (depends on 8)

The method of claim 8, wherein said substitution of said amino acid is selected from the group consisting of amino acid substitutions at positions 38, 215, 222 and 223.

### Claim 10 (depends on 5)

The method of claim 5, wherein said herpes simplex virus expresses two or more amino acid substitutions selected from the group consisting of substitutions at amino acid positions 215, 222, and 223 of the glycoprotein D (gD) ectodomain.
